Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.47M Sell
18,570
-1,374
-7% -$582K 2.53% 14
2026
Q2
$9.5M Buy
19,944
+5,099
+34% +$2.07M 2.54% 17
2026
Q1
$5.02M Buy
+14,845
New +$5.11M 2.41% 19
2024
Q3
– Sell
-8,850
Closed -$1.54M – 83
2024
Q2
$1.54M Buy
+8,850
New +$1.34M 0.63% 41
2023
Q3
– Sell
-7,055
Closed -$712K – 81
2023
Q2
$712K Buy
+7,055
New +$657K 0.46% 44
2021
Q1
– Sell
-7,540
Closed -$822K – 101
2020
Q4
$822K Buy
7,540
+3,500
+87% +$332K 0.43% 54
2020
Q3
$328K Buy
+4,040
New +$307K 0.2% 72

Other funds holding TSM

Geneva Partners's TSM Position: Q3 2026 in Review

Geneva Partners reduced its TSMC (TSM) stake by 6.9% in Q3 2026, selling an estimated $582K and leaving 18,570 shares worth $8.47M. The position accounts for 2.53% of the portfolio, ranked #14.

Geneva Partners first reported a position in TSM in Q3 2020 and has held it in 7 quarters since. The position peaked at $9.5M in Q2 2026. 2,055 funds tracked by Wall St. Rank hold TSM as of Q3 2026.

  • Geneva Partners held 18,570 shares of TSMC worth $8.47M as of Q3 2026.
  • Geneva Partners sold 1,374 TSMC shares in Q3 2026, an estimated $582K.
  • TSMC made up 2.53% of Geneva Partners's portfolio in Q3 2026, its #14 holding.
  • Geneva Partners first reported a position in TSMC in Q3 2020 and has held it in 7 quarters since.
  • Geneva Partners's TSMC position peaked at $9.5M in Q2 2026.
  • 2,055 funds tracked by Wall St. Rank held TSMC as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.